The global Pharmaceutical and Biopharmaceutical Safety Testing Service market size is predicted to grow from US$ 4400 million in 2025 to US$ 8750 million in 2031; it is expected to grow at a CAGR of 12.1% from 2025 to 2031.
Biosafety testing is a series of assays to evaluate the potential biological risks of new biological products, including viral testing, microbial testing, cell and molecular testing, and analytic testing. Health authorities such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) require all biopharmaceutical products and vaccines to undergo stringent testing to ensure the product is safe and free of contaminants.
United States market for Pharmaceutical and Biopharmaceutical Safety Testing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Pharmaceutical and Biopharmaceutical Safety Testing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Pharmaceutical and Biopharmaceutical Safety Testing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Pharmaceutical and Biopharmaceutical Safety Testing Service players cover Merck, Charles River Laboratories, Sartorius, Eurofins Scientific, SGS, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淧harmaceutical and Biopharmaceutical Safety Testing Service Industry Forecast鈥� looks at past sales and reviews total world Pharmaceutical and Biopharmaceutical Safety Testing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical and Biopharmaceutical Safety Testing Service sales for 2025 through 2031. With Pharmaceutical and Biopharmaceutical Safety Testing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical and Biopharmaceutical Safety Testing Service industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical and Biopharmaceutical Safety Testing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical and Biopharmaceutical Safety Testing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pharmaceutical and Biopharmaceutical Safety Testing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical and Biopharmaceutical Safety Testing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical and Biopharmaceutical Safety Testing Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical and Biopharmaceutical Safety Testing Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Raw Materials
Viral Banks
Cell Banks
Others
Segmentation by Application:
Pharmaceutical and Biotechnology Companies
CROs and CDMOs
Academic and Research Institutions
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Charles River Laboratories
Sartorius
Eurofins Scientific
SGS
Q2 Solutions
Samsung Biologics
Texcell
WuXi Biologics
Wuhan Canvest Biotechnology
Centre Testing International (CTI)
Suzhou Liangchen Biotechnology
JADE Biomedical
Standard Testing Group
Sino Tech World Biologicals
CAS Testing Technical Services
NTEK
Sino Biological
Miracle Points
Suzhou Cefety Bioscience
Zhejiang Hengyu Biological
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size (2020-2031)
2.1.2 Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Pharmaceutical and Biopharmaceutical Safety Testing Service by Country/Region (2020, 2024 & 2031)
2.2 Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Type
2.2.1 Raw Materials
2.2.2 Viral Banks
2.2.3 Cell Banks
2.2.4 Others
2.3 Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size by Type
2.3.1 Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 CROs and CDMOs
2.4.3 Academic and Research Institutions
2.5 Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size by Application
2.5.1 Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size by Player
3.1 Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Player (2020-2025)
3.1.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical and Biopharmaceutical Safety Testing Service by Region
4.1 Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size by Region (2020-2025)
4.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size Growth (2020-2025)
4.4 APAC Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size Growth (2020-2025)
4.5 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size by Country (2020-2025)
5.2 Americas Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size by Type (2020-2025)
5.3 Americas Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size by Region (2020-2025)
6.2 APAC Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size by Type (2020-2025)
6.3 APAC Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size by Country (2020-2025)
7.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size by Type (2020-2025)
7.3 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service by Region (2020-2025)
8.2 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Forecast
10.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast by Region (2026-2031)
10.1.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast by Region (2026-2031)
10.1.2 Americas Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.1.3 APAC Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.1.4 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.1.5 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.2 Americas Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.2.2 Canada 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.2.3 Mexico 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.2.4 Brazil 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.3 APAC Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast by Region (2026-2031)
10.3.1 China Pharmaceutical and Biopharmaceutical Safety Testing Service 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.3.3 Korea 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.3.4 Southeast Asia 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.3.5 India 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.3.6 Australia 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.4 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.4.2 France 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.4.3 UK 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.4.4 Italy 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.4.5 Russia 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.5 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.5.2 South Africa 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.5.3 Israel 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.5.4 Turkey 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
10.6 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast by Type (2026-2031)
10.7 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecast
11 Key Players Analysis
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.1.3 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Information
11.2.2 Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.2.3 Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Charles River Laboratories Main Business Overview
11.2.5 Charles River Laboratories Latest Developments
11.3 Sartorius
11.3.1 Sartorius Company Information
11.3.2 Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.3.3 Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Sartorius Main Business Overview
11.3.5 Sartorius Latest Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Information
11.4.2 Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.4.3 Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Eurofins Scientific Main Business Overview
11.4.5 Eurofins Scientific Latest Developments
11.5 SGS
11.5.1 SGS Company Information
11.5.2 SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.5.3 SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 SGS Main Business Overview
11.5.5 SGS Latest Developments
11.6 Q2 Solutions
11.6.1 Q2 Solutions Company Information
11.6.2 Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.6.3 Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Q2 Solutions Main Business Overview
11.6.5 Q2 Solutions Latest Developments
11.7 Samsung Biologics
11.7.1 Samsung Biologics Company Information
11.7.2 Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.7.3 Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Samsung Biologics Main Business Overview
11.7.5 Samsung Biologics Latest Developments
11.8 Texcell
11.8.1 Texcell Company Information
11.8.2 Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.8.3 Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Texcell Main Business Overview
11.8.5 Texcell Latest Developments
11.9 WuXi Biologics
11.9.1 WuXi Biologics Company Information
11.9.2 WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.9.3 WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 WuXi Biologics Main Business Overview
11.9.5 WuXi Biologics Latest Developments
11.10 Wuhan Canvest Biotechnology
11.10.1 Wuhan Canvest Biotechnology Company Information
11.10.2 Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.10.3 Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Wuhan Canvest Biotechnology Main Business Overview
11.10.5 Wuhan Canvest Biotechnology Latest Developments
11.11 Centre Testing International (CTI)
11.11.1 Centre Testing International (CTI) Company Information
11.11.2 Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.11.3 Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Centre Testing International (CTI) Main Business Overview
11.11.5 Centre Testing International (CTI) Latest Developments
11.12 Suzhou Liangchen Biotechnology
11.12.1 Suzhou Liangchen Biotechnology Company Information
11.12.2 Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.12.3 Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Suzhou Liangchen Biotechnology Main Business Overview
11.12.5 Suzhou Liangchen Biotechnology Latest Developments
11.13 JADE Biomedical
11.13.1 JADE Biomedical Company Information
11.13.2 JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.13.3 JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 JADE Biomedical Main Business Overview
11.13.5 JADE Biomedical Latest Developments
11.14 Standard Testing Group
11.14.1 Standard Testing Group Company Information
11.14.2 Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.14.3 Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Standard Testing Group Main Business Overview
11.14.5 Standard Testing Group Latest Developments
11.15 Sino Tech World Biologicals
11.15.1 Sino Tech World Biologicals Company Information
11.15.2 Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.15.3 Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Sino Tech World Biologicals Main Business Overview
11.15.5 Sino Tech World Biologicals Latest Developments
11.16 CAS Testing Technical Services
11.16.1 CAS Testing Technical Services Company Information
11.16.2 CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.16.3 CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 CAS Testing Technical Services Main Business Overview
11.16.5 CAS Testing Technical Services Latest Developments
11.17 NTEK
11.17.1 NTEK Company Information
11.17.2 NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.17.3 NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 NTEK Main Business Overview
11.17.5 NTEK Latest Developments
11.18 Sino Biological
11.18.1 Sino Biological Company Information
11.18.2 Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.18.3 Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 Sino Biological Main Business Overview
11.18.5 Sino Biological Latest Developments
11.19 Miracle Points
11.19.1 Miracle Points Company Information
11.19.2 Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.19.3 Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.19.4 Miracle Points Main Business Overview
11.19.5 Miracle Points Latest Developments
11.20 Suzhou Cefety Bioscience
11.20.1 Suzhou Cefety Bioscience Company Information
11.20.2 Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.20.3 Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.20.4 Suzhou Cefety Bioscience Main Business Overview
11.20.5 Suzhou Cefety Bioscience Latest Developments
11.21 Zhejiang Hengyu Biological
11.21.1 Zhejiang Hengyu Biological Company Information
11.21.2 Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Offered
11.21.3 Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.21.4 Zhejiang Hengyu Biological Main Business Overview
11.21.5 Zhejiang Hengyu Biological Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.